scholarly journals How to Evaluate Health-Related Quality of Life and Its Association with Medication Adherence in Pulmonary Tuberculosis – Designing a Prospective Observational Study in South Africa

2016 ◽  
Vol 7 ◽  
Author(s):  
Tanja Kastien-Hilka ◽  
Bernd Rosenkranz ◽  
Bryan Bennett ◽  
Edina Sinanovic ◽  
Matthias Schwenkglenks
Keyword(s):  
Quality Of Life ◽  
South Africa ◽  
Medication Adherence ◽  
Observational Study ◽  
Pulmonary Tuberculosis ◽  
Prospective Observational Study ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related

scholarly journals Association between Health-Related Quality of Life and Medication Adherence in Pulmonary Tuberculosis in South Africa

2017 ◽  
Vol 8 ◽  
Author(s):  
Tanja Kastien-Hilka ◽  
Bernd Rosenkranz ◽  
Matthias Schwenkglenks ◽  
Bryan M. Bennett ◽  
Edina Sinanovic
Keyword(s):  
Quality Of Life ◽  
South Africa ◽  
Medication Adherence ◽  
Pulmonary Tuberculosis ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related

scholarly journals P.014 OnabotulinumtoxinA-treated cervical dystonia patients report improvements in health-related quality of life in a prospective, observational study: POSTURe

2019 ◽  
Vol 46 (s1) ◽  
pp. S17
Author(s):  
M Petitclerc ◽  
M Cloutier ◽  
M Bhogal ◽  
G Davidovic
Keyword(s):  
Quality Of Life ◽  
Observational Study ◽  
Cervical Dystonia ◽  
Prospective Observational Study ◽  
Work Productivity ◽  
Final Visit ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related

Background: The clinical benefit of onabotulinumtoxinA in cervical dystonia (CD) is proven, but its impact on health-related quality of life (HRQoL) is largely unknown. Methods: Multicentre, prospective, observational study (NCT01655862) of CD patients treated with onabotulinumtoxinA at physician discretion (maximum 9 treatments). Patient-reported HRQoL outcomes and work productivity were collected at baseline, 4- or 8-weeks post-treatment, and final visit (prior to 9th treatment). OnabotulinumtoxinA utilization was assessed. Results: 61 patients received ≥1 treatment; 74.1% completed all treatments. Average total dose/treatment was 186.9U. The splenius capitis was most frequently treated (100% patients). Average pain numeric rating scale score was significantly improved at final visit (2.1) versus baseline (4.6; p<0.001) as were CD impact profile questionnaire-58 scores across all subscales (head/neck symptoms, pain/discomfort, sleep, upper limb activities, walking, annoyance, mood, psychosocial functioning; all p<0.001). Fewer patients (16.0%) reported loss of work productivity at final visit versus baseline (48.4%). 121 AEs were reported by 67.2% patients. 62 AEs in 44.3% patients were treatment-related, the most common being neck pain (18%). One serious AE (not treatment-related) was reported by 1 patient. No new safety signals were identified. Conclusions: Long-term use of onabotulinumtoxinA is a safe, effective treatment for CD, improving HRQoL and work productivity.

scholarly journals Immediate effect of CPAP titration on perceived health related quality of life: a prospective observational study

2016 ◽  
Vol 16 (1) ◽  
Author(s):  
Serena Iacono Isidoro ◽  
Adriana Salvaggio ◽  
Anna Lo Bue ◽  
Salvatore Romano ◽  
Oreste Marrone ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Observational Study ◽  
Prospective Observational Study ◽  
Perceived Health ◽  
Health Related Quality ◽  
Cpap Titration ◽  
Related Quality ◽  
Health Related

scholarly journals Wet Cupping Reduces Pain and Improves Health-related Quality of Life Among Patients with Migraine: A Prospective Observational Study

2019 ◽  
Vol 34 (2) ◽  
pp. 105-109 ◽  
Author(s):  
Abdullah Kaki ◽  
Rohaiem Sawsan ◽  
Mourad Samiha ◽  
Soad Al Jaouni ◽  
Mohsen Abdul Elalah ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Observational Study ◽  
Prospective Observational Study ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related
Sign in / Sign up

Export Citation Format

Share Document